Design and development of metal-organic framework-based nanocomposite hydrogels for quantification of deferiprone in exhaled breath condensate

Author:

Moharami Reza1,Karimzadeh Zahra1,Soleymani Jafar1,Jouyban-Gharamaleki Vahid2,Khoubnasabjafari Maryam2,Rahimpour Elaheh1,Jouyban Abolghasem1

Affiliation:

1. Tabriz University of Medical Sciences

2. Tabriz University of Medical Science

Abstract

Abstract

In this study, a novel fluorescence nanoprobe based on MIL-101 metal-organic frameworks embedding into the agarose hydrogel was fabricated using a hydrothermal technique and used for sensitive quantification of deferiprone in exhaled breath condensate (EBC) samples. The morphology and characterization of MIL-101/agarose nanocomposite hydrogel was studied by transmission electron microscopy, dynamic light scattering instrument, powder X-ray diffraction analysis, and Fourier transform infrared spectroscopy. The probe showed a reasonable fluorescence intensity quenching in the presence of deferiprone due to the interactions between iron centers in MIL-101 (Fe) and deferiprone, which likely formed non-fluorescent complexes. The proposed nanoprobe demonstrated a linear calibration curve in the range from 0.005 to 1.5 µg mL− 1 with a detection limit of 0.003 µg mL− 1. The intra- and inter-day precision for determinations of deferiprone with concentration of 1.0 µg mL− 1were 0.3% and 0.4% (n = 5), respectively. This method demonstrated high sensitivity and specificity towards deferiprone in the EBC samples and also presented a sensing platform with simplicity, convenience, fast implementation, and cost-effective in medical monitoring.

Publisher

Springer Science and Business Media LLC

Reference29 articles.

1. Development, Therapy, Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes;Kontoghiorghe CN,2016

2. Deferiprone: a review of its clinical potential in iron overload in β-thalassaemia major and other transfusion-dependent diseases;Barman Balfour JA,1999

3. A.J.C.m.c. Kolnagou, Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NAll and their combinations;Kontoghiorghes GJ,2005

4. Analytical approaches for the determination of deferiprone and its iron (III) complex: Investigation of binding affinity based on liquid chromatography-mass spectrometry (LC-ESI/MS) and capillary electrophoresis-frontal analysis (CE/FA);Asmari M,2020

5. Synthesis of a New Nanocomposite Based on Natural Asphalt and Its Application as a High-Performance and Eco-friendly Platform for the Electrochemical Determination of Deferiprone;Farokhi S,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3